248 results
8-K
EX-10.1
HBIO
Harvard Bioscience Inc.
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
no knowledge of any actions, causes of action, claims, demands, damages and liabilities of whatever kind or nature, in law or in equity, against
8-K
EX-10.1
HBIO
Harvard Bioscience Inc.
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
limitations imposed by applicable laws. To the extent that the scope or nature of benefits described in this section is determined under the Company policies … , and other matters which are of a proprietary or confidential nature, including but not limited to the Company’s and its affiliates’ and predecessors
SD
EX-1.01
mc6iyt80dp
20 May 22
Conflict minerals disclosure
4:15pm
8-K
EX-10.1
dctj9n9p 43xffeig
28 Apr 22
Entry into a Material Definitive Agreement
12:00am
SD
EX-1.01
zjpbnn1
27 May 21
Conflict minerals disclosure
4:26pm
8-K
EX-10.1
8yokiam
19 May 21
Departure of Directors or Certain Officers
4:20pm